The COVID-19 induced joint replacement deficit in England, Wales and Northern Ireland by Sayers, Adrian E et al.
                          Sayers, A. E., Deere, K. C., Lenguerrand, E., Kunutsor, S. K., Rees,
J., Judge, A., Ben-Shlomo, Y., Gregson, C. L., Clark, E. M., Reed, M.,
Wilton, T., Pegg, D. J., Wilkinson, J. M., & Price, A. (2021). The
COVID-19 induced joint replacement deficit in England, Wales and
Northern Ireland. (UnderReview).
Early version, also known as pre-print
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
The COVID-19 induced joint replacement deficit in England, Wales and Northern Ireland 
Adrian Sayers PhD,1 Kevin DeereMSc, 1 Erik LenguerrandPhD, 1 Setor K Kunutsor PhD,1+2 Jonathan L 
ReesMD,3+9 Andy Judge PhD,1 Yoav Ben-Shlomo PhD,1+4 Celia L Gregson PhD,1 Emma M Clark MD, PhD,1 Mike 
ReedMD5, Timothy WiltonMA6, Derek J PeggFRCS Ed(Tr&Orth)7, Jeremy M WilkinsonPhD8, Andrew PriceDPhil3+9, 
Michael R Whitehouse PhD1+2, Ashley W. Blom PhD1+2 
1. Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st 
Floor Learning & Research Building, Southmead Hospital, Bristol, BS10 5NB, UK 
2. National Institute for Health Research Bristol Biomedical Research Centre, University 
Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol 
3. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar 
Research Centre, University of Oxford, Oxford, OX3 7LD, UK 
4. Population Health Sciences, University of Bristol, Bristol BS8 2PS 
5. Northumbria Healthcare NHS Foundation Trust, Department of Trauma and Orthopaedics, 
Wansbeck General Hospital, Woodhorn Lane, NE63 9JJ, UK 
6. Department of Orthopaedics, Royal Derby Hospital, Uttoxeter Rd, Derby, DE22 3NE, UK 
7. Mid Cheshire Hospitals NHS Foundation Trust, Leighton Hospital, Middlewich Road, Crewe, 
Cheshire, CW1 4QJ 
8. Department of Oncology and Metabolism, The University of Sheffield, Sorby Wing, Northern 
General Hospital, Sheffield, S5 7AU, UK 
9. National Institute for Health Research Oxford Biomedical Research Centre, Oxford University 
Hospitals Foundation Trust. 
Correspondence to:  
Dr Adrian Sayers 
Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, 1st Floor 





The COVID-19 pandemic has impacted health, economies and the functioning of societies globally. In 
addition to direct health effects, it has indirectly impacted population health by limiting access to 
non-COVID treatments, including joint replacements. The pandemic has necessitated re-organisation 
of healthcare with the private-sector providing support to public hospitals in some areas. The full 
impact is therefore difficult to ascertain from public data sources alone. 
Methods 
We used a mandatory prospective national register of private and publicly funded hip, knee, 
shoulder, elbow and ankle replacements in England, Wales and Northern Ireland. Descriptive 
analysis of the provision of joint replacement comparing data from 2019 to 2020 and predicted 
deficit recovery. 
Findings 
There was a substantial deficit in the provision of joint replacement in 2020 compared to 2019 with 
106,922(48.8%) fewer procedures performed; resulting in 45,116 (44%) fewer hip replacements, 
57,115(52%) fewer knee replacements, 3,878(50%) fewer shoulder replacements, 280 (33%) fewer 
elbow replacements and 533(53%) fewer ankle replacements performed. Wales and Northern 
Ireland were disproportionately affected with an overall reduction of 8,001(67%) and 2,833(64%) 
respectively compared to 96,088(47%) in England. 
An immediate 5% expansion in provision from the 2019 baseline will eliminate the deficit over 
approximately 10 years (by 2031), whilst a 10% expansion will address the deficit by 2026.  
Interpretation 
This large national analysis of both private and publicly funded joint replacements illustrates a 
substantial accumulated deficit of surgery, equivalent to six-months of normal activity across 
England, Wales and Northern Ireland, due to the indirect effects of COVID-19. As the pandemic 
evolves, further waves of infection are likely to restrict surgery and see the deficit increase, 
therefore projections of time taken to address the deficit must thus be regarded as the best-case 
scenario. A significant expansion of joint replacement services compared 2019 is urgently required 
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Joint replacement is a common and important surgical procedure used to treat a variety of 
musculoskeletal problems including osteoarthritis and acute trauma. It is a highly successful 
procedure that reduces pain and disability enabling participation in and contribution to society. The 
Lancet described joint replacement as the operation of the 20th century.1 Over 200,000 primary hip 
and knee replacements were performed in England, Wales and Northern Ireland in 2019 2. Joint 
replacements are long-lasting, with over half of hip and knee replacements lasting in excess of 25 
years3,4 and 90% of shoulder replacements lasting in excess of 10 years.5 For very many people it is a 
curative procedure for the debilitating effects of end-stage arthritis.  
The COVID-19 pandemic has had an unprecedented impact on populations around the world. The 
first patient with COVID-19 in the UK was identified on the 23rd January 20206 and the first UK 
national lockdown commenced on 23rd March 20207. The pandemic has impacted our lives widely 
and has inevitably required in a massive and rapid re-organisation of healthcare provision in order to 
provide care for patients with severe acute respiratory distress due to SARS-Cov2 infection.  
Less urgent medical procedures have been forgone or deferred due to competing pandemic 
demands. We have seen a re-organisation of services from public to the private sector and some 
hospitals have specialised in “COVID care”, whereas others have attempted to remain “COVID free” 
in an effort to provide more routine services. Early reports have suggested that mortality is 
persistently high (20.4%) following the acquisition of COVID-19 in the perioperative period after 
elective surgery.8 Reports from around the world have suggested a wide variety of consequences of 
healthcare reorganisation including a reduction in the volume of joint replacement9-13, an increased 
number of patients with symptoms “worse than death” whilst waiting for joint replacement14, 
increased waiting lists15 and economic hardship16. However, the majority of these reports have been 
based on single centres with small sample sizes. Assessing the impact of COVID-19 on the provision 
of joint replacement is difficult due to the shift in surgeries from the public to the private sector and 
the effective commandeering of private hospitals by NHS trusts. The analysis of single centres, public 
sector or private sector databases maybe misleading as they are unable to consider the totality of a 
healthcare system that has become increasingly integrated during this pandemic. A comprehensive 
analysis of both private and public sector provision is required to understand the impact of COVID-
19 and plan the recovery of joint replacement capacity. Fortunately, England, Wales and Northern 
Ireland have an integrated mandatory register “The National Joint Registry” for all hip, knee, 
shoulder, elbow and ankle joint replacements. 
We aim to describe the impact of the COVID-19 pandemic on joint replacement services in England, 
Wales and Northern Ireland and quantify the expansion of services required in order to address the 
accumulated deficit of joint replacement surgery and return joint replacement service provision back 




In this prospective observational registry-based study we analysed data from the National Joint 
Registry (NJR)2. We collected data on hip, knee, shoulder, elbow and ankle primary joint 
replacement procedures entered into the registry from hospitals in England, Wales and Northern 
Ireland since its inception in April 2003 through to the end of December 2020. A data quality audit in 
2017/18 showed over a 95% and 96% capture of all primary hip and knee data respectively (though 
this has subsequently been significantly improved by national audits)2 .  
The NJR data was prepared for this analysis in the same manner as described in the NJR 2020 17th 
Annual Report.2 Data were cleaned by removing records with missing information, removing 
duplicate procedures, and removing records where we were unable to ascertain a logical sequence 
of revision procedures. The cleaning process resulted in 2,789,980 primary procedures for analysis 
(see supplementary figures 1 to 5).  
Statistical Analysis 
We used descriptive statistics to illustrate the impact of COVID-19 on the provision of joint 
replacement since the start of data collection for each type of joint replacement, dividing 
procedures into acute (those performed for trauma) and elective indications where possible. 
We present weekly counts of procedures in 2019 compared to 2020 by each joint, dividing 
procedures into acute and elective indications where possible, and include a 21-day weekly rolling 
average. 
The time-to-recovery and expansion in services required compared to 2019 was also calculated. We 
assume the years-to-recovery is estimated by deficit in procedures expressed as a percentage 
expansion of services compared to 2019 i.e. a 50,000 procedure deficit will take 5 years to recover 
assuming a baseline provision of 100,000 patients and a 10% expansion in surgical provision. We 
have simplistically assumed a static baseline (2019) though the secular patterns prior to this suggest 
the need for increasing service provision (with the possible exception of knee replacement) so these 
estimates are likely to be conservative. 






Time-to-recovery was calculated for England, Wales and Northern Ireland overall and for each nation 
separately. 
Sensitivity analyses 
Weekly frequencies were also calculated for all English sub-regions for all joints in 2020, dividing 
procedures into acute and elective indications where possible. Time-to-recovery was also calculated 
for all English sub-regions for all joints comparing provision to 2019. All analyses were conducted in 
Stata 15.1 StataCorp. College Station, TX. 
Role of the funding source 
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. AS, KD, EL had full access to all the data in the study and all 




Overall, 106,922 (48.8%) fewer joint (hip, shoulder, elbow, ankle) replacements were performed in 
2020 compared to 2019. Knee replacements showed the largest reduction in absolute numbers 
followed by hip replacements, see Table 1. Wales and Northern Ireland have recorded 67% and 64% 
fewer joint replacement procedures respectively compared to 2019, which is substantially greater 
than the deficit of 47% experienced by England.  
Table 1: Descriptive statistics of provision and change of joint replacement by joint and nation. 
Joint N(2019) N(2020)= N(Change) %(Change) 
England, Wales and Northern Ireland 
Hip 100,940 55,824 -45,116 -44.7 
Knee 108,607 51,492 -57,115 -52.6 
Shoulder 7,737 3,859 -3,878 -50.1 
Elbow 850 570 -280 -32.9 
Ankle 1,009 476 -533 -52.8 
Total 219,143 112,221 -106,922 -48.8 
England 
Hip 93,148 52,818 -40,330 -43.3 
Knee 100,547 49,169 -51,378 -51.1 
Shoulder 7,373 3,736 -3,637 -49.3 
Elbow 791 552 -239 -30.2 
Ankle 961 457 -504 -52.4 
Total 202,820 106,732 -96,088 -47.4 
Wales 
Hip 5,501 2,039 -3,462 -62.9 
Knee 6,025 1,734 -4,291 -71.2 
Shoulder 287 97 -190 -66.2 
Elbow 43 9 -34 -79.1 
Ankle 32 8 -24 -75.0 
Total 11,888 3,887 -8,001 -67.3 
Northern Ireland 
Hip 2,291 967 -1,324 -57.8 
Knee 2,035 589 -1,446 -71.1 
Shoulder 77 26 -51 -66.2 
Elbow 16 9 -7 -43.8 
Ankle 16 11 -5 -31.3 
Total 4,435 1,602 -2,833 -63.9 
 
Figure 1 illustrates the difference in accrual of primary joint replacements since the start of data 
collection for each joint. Data have illustrated that provision of joint replacement has increased year 
on year since data collection started. 
Figure 1: Annual number of primary hip, knee, shoulder, elbow and ankle replacements performed 
in England, Wales and Northern Ireland. 
 
 
Figures 2 and 3 illustrate weekly counts of primary hip, knee, shoulder, elbow and ankle 
replacements in 2019 compared to 2020.  These show a rapid decline in the number of procedures 
prior to the start of the first national lockdown. A very small number of elective joint replacements 
were performed in the first 8 weeks following the first national lockdown. The volume of acute 
procedures (those performed for trauma) recorded in hip, shoulder and elbow replacements were 
also reduced in 2020 compared to 2019. 
Figure 2: Weekly number of primary hip and knee replacements performed in England, Wales, and 
Northern Ireland in 2019 and 2020. 
 
Figure 3: Weekly number of primary shoulder, elbow and ankle replacements performed in England, 
Wales, and Northern Ireland in 2019 and 2020. 
 
Figure 4 shows a breakdown of weekly counts of primary hip, knee, shoulder, elbow and ankle 
replacements in 2020 stratified by each nation. This shows that the reduced volume of joint 
replacements is not evenly distributed across England, Wales and Northern Ireland. The volume of 
procedures recorded in Wales and Northern Ireland in the second quarter of the year (2020) is 
negligible compared to those recorded in England. This pattern is even more pronounced for 
shoulder, elbow and ankle procedures in the 2nd, 3rd and 4th quarters of 2020. 
Figure 4: Weekly number of primary shoulder, elbow and ankle replacements performed in England, 
Wales, and Northern Ireland in 2020 by nation. 
 
Supplementary figures 6 through to 10 and Supplementary Table 1 illustrate regional breakdown of 
weekly counts of primary hip, knee, shoulder, elbow and ankle replacements in 2020. 
Supplementary figure 6 and 7 demonstrates heterogeneity in the recovery of hip and knee 
replacements from the first wave of COVID-19 infections, with some regions beginning restoring 
provision more rapidly, and to a greater extent, than others. 
Figure 5 illustrates the years-to-recovery following expansion of provision compared to 2019 rates 
across England, Wales and Northern Ireland stratified by joint. This figure illustrates that an 
immediate 5% expansion in provision of hip, knee, shoulder, and ankle replacement compared to 
2019 may address the deficit in procedures, within approximately 10 years. A 10% expansion in 
provision is projected to address the current deficit in approximately 5 years. 
Figure 5: Predicted years-to-recovery of the 2020 deficit of joint replacement procedures following 
expansion of joint replacement provision compared to 2019 in England, Wales and Northern Ireland. 
 
Figure 6 illustrates the years-to-recovery following expansion of provision compared to 2019 
stratified by England, Wales and Northern Ireland and joint type. Figure 6 and data in Table 2 
illustrate that the recovery in Wales and Northern Ireland will take longer for an equivalent 
expansion in services. 
  
Figure 6: Predicted years-to-recovery of the 2020 deficit of joint replacement procedures following 
expansion of joint replacement provision compared to 2019 stratified by nation. 
 
Supplementary figure 11 and supplementary Table 2 illustrates years-to-recovery following 
expansion of provision compared to 2019 stratified by region and joint type. These data illustrate 
heterogeneity in provision of joint replacement during 2020 and different recovery profiles in the 3rd 
and 4th quarters of 2020. 
  
Table 2 predicted years-to-recovery of 2020 deficit following expansion of joint replacement 
provision compared to 2019 by joint type and nation. 
Expansion compared 
to 2019 (%) 
Years to recovery 
Hip Knee Shoulder Elbow Ankle 
England, Wales and Northern Ireland 
5 8.9 10.5 10.0 6.6 10.6 
10 4.5 5.3 5.0 3.3 5.3 
15 3.0 3.5 3.3 2.2 3.5 
20 2.2 2.6 2.5 1.6 2.6 
25 1.8 2.1 2.0 1.3 2.1 
30 1.5 1.8 1.7 1.1 1.8 
England 
5 8.7 10.2 9.9 6.0 10.5 
10 4.3 5.1 4.9 3.0 5.2 
15 2.9 3.4 3.3 2.0 3.5 
20 2.2 2.6 2.5 1.5 2.6 
25 1.7 2.0 2.0 1.2 2.1 
30 1.4 1.7 1.6 1.0 1.7 
Wales 
5 12.6 14.2 13.2 15.8 15.0 
10 6.3 7.1 6.6 7.9 7.5 
15 4.2 4.7 4.4 5.3 5.0 
20 3.1 3.6 3.3 4.0 3.8 
25 2.5 2.8 2.6 3.2 3.0 
30 2.1 2.4 2.2 2.6 2.5 
Northern Ireland 
5 11.6 14.2 13.2 8.8 6.3 
10 5.8 7.1 6.6 4.4 3.1 
15 3.9 4.7 4.4 2.9 2.1 
20 2.9 3.6 3.3 2.2 1.6 
25 2.3 2.8 2.6 1.8 1.3 




We present the first comprehensive assessment of the provision of joint replacement across the 
entire health service (private and public) in England, Wales and Northern Ireland. The COVID-19 
pandemic has had a profound impact on patients due to reduced service delivery of joint 
replacement surgery. Provision of joint replacement surgery in 2020 was reduced by approximately 
50% compared to 2019. Patients requiring elective joint replacement have been impacted the most 
with acute trauma provision being largely preserved throughout 2020. The impact of COVID-19 has 
not been uniform across or within the nations covered by the NJR. Wales and Northern Ireland have 
seen the greatest reduction in capacity with surgery for patients requiring elective shoulder, elbow 
and ankle replacements effectively being halted.  
We illustrate that to recover the accumulated deficit in joint replacement that has occurred in 2020 
a significant expansion in pre-pandemic service provision is needed, even if it is assumed that 
demand remains static at 2019 levels, which is unlikely to be true given the year-on-year secular 
increase in the provision of most procedures except possibly knee replacement. The deficit in 2020 is 
equivalent to six-months of normal activity across England, Wales and Northern Ireland. Without 
expansion in provision, waiting lists for joint replacement will be, at a minimum six-months longer 
compared to pre-pandemic levels based on the assumption that services have been restored since 
January 2021. However, as provision had not recovered to pre-pandemic levels by the end of 2020, it 
is likely that the pandemic will continue to impact patients due to reduced provision of joint 
replacement services for at least the first half of 2021. Waiting lists will therefore continue to 
lengthen as the deficit increases.   
Expanding provision in the post-pandemic NHS system will be challenging. Either greater 
productivity, equivalent to every hospital providing an additional 2.5 or 5 weeks of joint replacement 
provision per year, must be achieved which is unlikely to be feasible. An alternative strategy would 
be a 5% or 10% expansion in services crudely represents 10 or 20 new high volume treatment 
centres each providing 500 hip and 500 knee joint replacements per year. Staffing such facilities and 
providing all the ancillary care would also be extremely challenging.  Any additional theatre capacity 
developed will require consultant orthopaedic surgeons, anaesthetic staff, theatre staff, nurses, 
physiotherapists and all the other ancillary services. Expanding staff capacity cannot take place 
overnight and presents the most serious challenge. Utilisation and efficiency solutions are likely to 
offer only a partial answer. Caution must also be exercised when attempting to expand capacity 
within existing staff, ensuring they are retained and supported in order that work-related “burn-out” 
due to COVID-19 is not exacerbated. Similarly, the increased volume of post discharge care will have 
significant resource implications and impact on already stretched community-based services.  
The removal of barriers to increasing capacity, such as annual17 and lifetime pension allowances,18 
will be as important as incentivising 7-day a week operating, asking senior orthopaedic surgeons and 
anaesthetists to delay their retirement or asking recently retired surgeons and anaesthetists to 
return from retirement to assist in the provision of joint replacement are all strategies to be 
considered. Expanding bed capacity will be particularly difficult during winter months when, even 
prior to the pandemic, elective surgery is already routinely curtailed. Minimising seasonal variation 
in the volume of primary procedures performed will be essential in maximising service delivery; the 
role of private sector service provision is likely to be increasingly important in restoring provision of 
joint replacement. 
The selection of evidence based joint replacement19,20 and rehabilitation strategies which are cost-
effective21 and minimise the national healthcare and revision burden will be essential in maximising 
capacity of primary procedures, with NHS initiatives such as “Getting It Right First Time”22 playing an 
important role. The rapid assessment of the clinical and cost-effectiveness of new treatment 
modalities, such as day case joint replacement,23 and enhanced recovery programmes24 are required 
if the capacity for primary joint replacement is to be maximised.  
 
Strengths and limitations 
This analysis has a number of strengths. Importantly the data included in this analysis covers both 
private and publicly funded joint replacement procedures. Contribution to the registry is mandatory 
and primary case ascertainment is in excess of 95% for hip and knee replacements.2 
We assume the latent demand for joint replacement will be the same as 2019, we have not 
accounted for the increased demand in joint replacement we have seen historically, which is 
approximately 5% per year.2 We have not factored in the reduced demand for joint replacement due 
to the higher expected mortality in 2020, similarly we have also not accounted for the observed 
modest reduction in trauma related procedures in 2020, which we assume will have been treated 
using alternative strategies, e.g. hemiarthroplasty rather than total hip replacement as was 
recommended by NHS England in March 2020, in response to the demands of the pandemic25, for 
patients with intracapsular hip fractures26 or conservative management. We are under-estimating 
the impact on elective hip, shoulder and elbow joint replacement, as surgery for traumatic 
indications has been largely preserved throughout 2020. We also expect a modest lag in data entry, 
which principally reduces volume estimates in the fourth quarter of 2020 (typically there is less than 
5% late data entry beyond three months). There may also be a reduction in compliance in reporting 
procedures to the NJR because of indirect effects of the allocation of administrative staff during the 
COVID-19 pandemic response in individual hospitals. The model used to predict time-to-recovery is 
simplistic and has not accounted for demographic changes including an increasingly elderly 
population nor increasing life expectancy that we have historically observed. This analysis only 
considers the impact of the pandemic on activity in 2020, the pandemic principally impacted 
provision in the last three quarters of 2020 and has continued to effect provision in 2021 and are 
likely to make predictions very conservative. 
Conclusion 
We have been able to reliably assess the impact on patients waiting for joint replacement, created 
by the effects of COVID-19 in 2020, using a nationally representative data source. The provision of 
primary joint replacement declined by approximately 106,000 cases (50%) in 2020 in England, Wales 
and Northern Ireland. This will inevitably lead to a large number of patients enduring unnecessary 
pain, disability and secondary decline in mental and overall physical well-being. The impact on 
waiting times, in an already overstretched healthcare system, is extremely concerning and likely to 
deteriorate further in 2021 at least. Returning to pre-pandemic provision is not sufficient, as this will 
not address the deficit in joint replacement and even with a rapid expansion in service provision to 
address this deficit in provision, our study indicates it will take many years to resolve this joint 
replacement crisis.  
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